Full Preclinical Validation of the 123i-Labeled Anti-Psma Antibody Fragment ScFvD2B for Prostate Cancer Imaging
Oncotarget - United States
doi 10.18632/oncotarget.14229
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 26, 2016
Authors
Publisher
Impact Journals, LLC